Intravitreal Bevacizumab for Photodynamic Therapy-Induced Massive Macular Detachment in Acute Central Serous Chorioretinopathy

Publisher： Karger

E-ISSN： 1663-2699|3|2|196-199

ISSN： 1663-2699

Source： Case Reports in Ophthalmology, Vol.3, Iss.2, 2012-06, pp. : 196-199

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreal Bevacizumab to Treat Acute Central Serous Chorioretinopathy: Short-Term Effect

By  

Ophthalmologica, Vol. 223, Iss. 5, 2009-06 ,pp. : 343-347

Karger

Access to resources Recommend Favorite

Hemorrhagic Macular Infarction after Intravitreal Bevacizumab for Chronic Multifocal Central Serous Chorioretinopathy

By  

Case Reports in Ophthalmology, Vol. 5, Iss. 2, 2014-07 ,pp. : 207-211

Karger

Access to resources Recommend Favorite

Intravitreal Ranibizumab for Acute Central Serous Chorioretinopathy

By  

Ophthalmologica, Vol. 229, Iss. 3, 2012-12 ,pp. : 152-157

Karger

Access to resources Recommend Favorite

Risk Factors for Recurrence of Serous Macular Detachment in Untreated Patients with Central Serous Chorioretinopathy

By  

Ophthalmic Research, Vol. 46, Iss. 3, 2011-03 ,pp. : 160-163

Karger

Access to resources Recommend Favorite

Fundus Autofluorescence before and after Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

By  

Ophthalmologica, Vol. 223, Iss. 4, 2009-04 ,pp. : 263-268

Karger

Access to resources Recommend Favorite